📉 The Financial Deep Dive
Coromandel International Limited announced its financial results for the third quarter and nine months ended December 31, 2025, showcasing robust top-line growth alongside a significant interim dividend declaration.
The Numbers:
- Standalone Q3 FY26: Revenue from operations surged by 22.11% YoY to ₹8,457.33 Cr, while Profit After Tax (PAT) saw a marginal increase of 0.86% YoY to ₹529.71 Cr. Basic Earnings Per Share (EPS) stood at ₹17.97, up 0.67% YoY.
- Standalone 9M FY26: Revenue grew by 30.39% YoY to ₹24,869.99 Cr, and PAT increased by 19.48% YoY to ₹1,854.27 Cr. Basic EPS was ₹62.95, up 19.72% YoY.
- Consolidated Q3 FY26: Revenue rose by 26.59% YoY to ₹8,779.45 Cr. However, PAT declined by 3.83% YoY to ₹488.47 Cr, with basic EPS at ₹17.17, down 1.27% YoY.
- Consolidated 9M FY26: Revenue grew by 33.40% YoY to ₹25,475.88 Cr, and PAT increased by 20.81% YoY to ₹1,783.50 Cr. Basic EPS was ₹61.53, up 21.77% YoY.
The Board also approved an interim dividend of ₹9 per equity share (900%) for FY25-26.
The Quality:
The top line demonstrates strong momentum, with consolidated revenue expanding significantly, bolstered by the acquisition of NACL Industries Limited. This acquisition, effective August 8, 2025, with further stake acquired on December 31, 2025, is a key driver. However, the consolidated PAT saw a slight dip in Q3 FY26. This divergence between revenue and PAT on a consolidated basis is attributed to the initial accounting for the NACL acquisition, which is provisionally determined and affects period comparability, suggesting potential acquisition-related costs or adjustments.
Segment-wise, the 'Nutrient and other allied business' remains the larger contributor, reporting ₹7,752.81 Cr in revenue and ₹611.95 Cr in segment results for Q3 FY26. The 'Crop protection' segment posted ₹785.11 Cr in revenue and ₹158.13 Cr in results.
🚩 Risks & Outlook:
The primary concern for investors is the reduced comparability of consolidated financial figures due to the NACL Industries acquisition. Understanding the normalized performance post-acquisition integration will be crucial. While the Q3 consolidated PAT decline warrants attention, the strong revenue growth and the interim dividend declaration suggest underlying business strength. The absence of specific forward-looking guidance from management means investors will need to monitor operational execution and integration progress closely in the upcoming quarters.